Dergiler / Eurasian Journal of Medicine and Oncology / 2020 / Cilt: 4 - Sayı: 2

The Impacts of Covariates on Spatial Distribution of Corona Virus 2019 (COVID-19): What Do the Data Show through ANCOVA and MANCOVA?

Sayfa
141–148
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Healthcare providers should follow subsequent reports as the situation will likely change promptly.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In late December 2019, a cluster of cases with 2019 Novel Coronavirus pneumonia (SARS-COV-2) in Wuhan, Chine, aroused worldwide concern.
📊
Temel Bulgular & Veri:Even though an accurate estimate of the case-fatality risk is difficult; this research is useful to mitigate the spatial pattern of COVID-19.
💡
Sonuç & Katkı:Healthcare providers should follow subsequent reports as the situation will likely change promptly.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: In late December 2019, a cluster of cases with 2019 Novel Coronavirus pneumonia (SARS-COV-2) in Wuhan, Chine, aroused worldwide concern. This novel virus is becoming a nightmare and a serious health problem across the globe. Even though an accurate estimate of the case-fatality risk is difficult; this research is useful to mitigate the spatial pattern of COVID-19. Our aim to assess the impacts of covariates (age, sex, blood type, and disease severity, previous health history of patients, transmission type, and location) on spatial distribution of COVID-19. Methods: Relevant data are obtained from the world health organization released by March 18, 2020 and some other information from published works is taken into consideration. The data are analyzed using descriptive statistics, t-test, Analysis of Covariance (ANCOVA) and Multivariate Analysis of Covariance (MANCOVA) through STATA packages. Results: The spatial pattern of COVID-19 is varying with more than half millions of confirmed cases and thousands of deaths globally. The result of the study has also shown that the spatial pattern of COVID-19 is fluctuating, where in Republic of China, Italy, USA and Iran major confirmed cases and deaths are reflected. There is also an evidence as age and population density variation has statistically significant relationship with deaths due to COVID-19 (Fcal=133.909 and Pvalue= 0.000*). The result also pointed out as there is statistical significant difference between male and female being affected by this COVID-19. The contagion fatality death ratio within 0-9 years is almost none; while for patients above 50 years is comparatively an agony. There is also statistical evidence on the outburst of the epidemic in Europe, America and Western Pacific Region the local transmission is predominant, while in Africa and in other territorial regions majority of the cases are smuggled. In spite of some diversity in initial symptoms, utmost of COVID-19 patients have fever and respiratory symptoms. Social distancing, special care for elders and patients with habits of smoking cigarette, diabetes, pressure and cancer is recommended. The government and private Medias should work in giving awareness about the transmission of the pandemic. Healthcare providers should follow subsequent reports as the situation will likely change promptly.

🔖

Bu Makaleye Atıf Yap

LİKASSA, H. T. (2020). The Impacts of Covariates on Spatial Distribution of Corona Virus 2019 (COVID-19): What Do the Data Show through ANCOVA and MANCOVA?. Eurasian Journal of Medicine and Oncology, Cilt: 4 - Sayı: 2, 141–148. https://ajindex.com/articles/125278

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrobial Agents. 2020 Feb 17:105924. doi: 0.1016/j. ijantimicag.2020.105924. [Epub ahead of print]
  2. Wang LS, Wang YR, Ye DW, Liu QQ. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence”. Int J Antimicrob Agents. 2020 [Epub ahead of print]
  3. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. [https://www.who.int/dg/ speeches/detail/who-director-general-s-opening-remarks-at the-media-briefing-on-covid-19---11-march-2020]
  4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print] 5. Santé Publique France. Infection au nouveau Coronavirus (SARS-CoV-2), COVID-19, France et Monde [https://www.santepubliquefrance. fr/maladies-et-raumatismes/maladies-et infections-respiratoires/infection-a-coronavirus/articles/infection- au-nouveau-coronavirussars-cov-2-covid-19-franceet- monde] 6. Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV2. Int J Antimicrob Agents. 2020 Feb 15:105923. doi: 10.1016/j.ijantimicag.2020.105923. [Epub ahead of print]
  5. Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 [Epub ahead of print]
  6. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;10-0282
  7. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020 Feb 19. doi: 10.5582/bst.2020.01047. [Epub ahead of print]
  8. Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:185-8
  9. Philippe Gautret, Jean-Christophe Lagier and Didier Raoult[2020]: Hydr